Search research articles
Contact Us
Filters
Showing results (201-210 of 663) with videos related to
Page
of 67
Sort By:
Future Oncology (London, England)
|
March 5, 2019
Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
Heinz Ludwig, Carsten Bokemeyer, Matti Aapro, et al.
Leukemia & Lymphoma
|
March 11, 2017
MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma
Nuray Akyüz, Nadine Albert-Konetzny, Christiane Pott, et al.
Hamostaseologie
|
February 9, 2024
Multisite Thrombosis in a Patient with Paroxysmal Nocturnal Hemoglobinuria
Lennart Beckmann, Tobias D Faizy, Fabian Flottmann, et al.
Leukemia & Lymphoma
|
August 8, 2023
The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis
Franziska Modemann, Paymon Ahmadi, Philipp H von Kroge, et al.
Diagnostic Pathology
|
July 26, 2015
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Nathaniel Melling, Johanna Muth, Ronald Simon, et al.
European Urology
|
June 28, 2011
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors
Karin Oechsle, Christian Kollmannsberger, Friedemann Honecker, et al.
The Journal of Pathology
|
June 29, 2004
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells
Friedemann Honecker, Hans Stoop, Ronald R de Krijger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 27, 2015
Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)
Pere Gascón, Matti Aapro, Heinz Ludwig, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2012
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials
Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier, et al.
Plos One
|
April 23, 2014
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency
Lars Harbaum, Jan K Hennigs, Hans J Baumann, et al.
Page
of 67
Search research articles
Search
Showing results (201-210 of 663) with videos related to
Sort By:
Page
of 67
Future Oncology (London, England)
|
March 5, 2019
Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study
Heinz Ludwig, Carsten Bokemeyer, Matti Aapro, et al.
Leukemia & Lymphoma
|
March 11, 2017
MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma
Nuray Akyüz, Nadine Albert-Konetzny, Christiane Pott, et al.
Hamostaseologie
|
February 9, 2024
Multisite Thrombosis in a Patient with Paroxysmal Nocturnal Hemoglobinuria
Lennart Beckmann, Tobias D Faizy, Fabian Flottmann, et al.
Leukemia & Lymphoma
|
August 8, 2023
The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis
Franziska Modemann, Paymon Ahmadi, Philipp H von Kroge, et al.
Diagnostic Pathology
|
July 26, 2015
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Nathaniel Melling, Johanna Muth, Ronald Simon, et al.
European Urology
|
June 28, 2011
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors
Karin Oechsle, Christian Kollmannsberger, Friedemann Honecker, et al.
The Journal of Pathology
|
June 29, 2004
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells
Friedemann Honecker, Hans Stoop, Ronald R de Krijger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 27, 2015
Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)
Pere Gascón, Matti Aapro, Heinz Ludwig, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2012
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials
Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier, et al.
Plos One
|
April 23, 2014
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency
Lars Harbaum, Jan K Hennigs, Hans J Baumann, et al.
Page
of 67